Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05792501
Other study ID # Complication Of MV IN PICU
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date April 1, 2022
Est. completion date June 30, 2023

Study information

Verified date March 2023
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to determine the incidence, risk factors and outcome of ventilation associated common complication in the PICUs at Assiut University Children Hospital in Egypt.


Description:

A constellation of adverse effects and complications may be associated with mechanical ventilation,The following are the Commonest Complications of Mechanical Ventilation 1. Ventilator-associated pneumonia. 2. Ventilator-induced lung injury. 3. Ventilation induce Hemodynamic compromise leads to ARDS. Ventilator-Associated Pneumonia (VAP) It refers to nosocomial pneumonia occurring 48 hours or more after initiation of mechanical ventilation (MV) It is the second most common HAI after blood stream infection in the paediatric age group, accounting for about 20% of all HAIs in the paediatric intensive care units (PICUs) and has a rate of 2.9- 21.6 per 1000 ventilator days.The risk factors responsible for VAP occurrence can be classified into: A-Host related factors: include associated co-morbidities B-Device-related factors: include the endotracheal tube, the ventilation circuit, and the presence of a nasogastric or an orogastric tube. C-Personnel related factors: include improper hand hygiene and inadequate use of personal protective equipment. VAP is associated with increased hospital morbidity; mortality; duration of hospitalization by an average of 7-9 days per patient; and health care costs . The incidence rates of VAP are higher in developing countries with limited resources. Ventilator-associated lung injury (VALI) It is the lung damage by application positive or negative pressure to the lung by mechanical ventilation. The prevalence of VALI in children admitted to the paediatric intensive care unit (PICU) may approximate 10%. Types of VALI: - Voltrauma (This is damage caused by over-distension) - Barotrauma (destructive entry of pressurised airway gases into the parenchyma, or into blood vessels.) - Biotrauma (is known to upregulate pulmonary cytokine production) - Oxygen toxicity (This is the damage caused by a high concentration of inspired oxygen) - Recruitment /de-recruitment injury (atelectotrauma) - Shearing injury Risk factors for VALI: blood product transfusion, acidaemia, and history of restrictive lung disease. larger tidal volume. investigators observed lower mortality among children ventilated with Vt ~8 mL/kg actual bodyweight compared with ~10 mL/kg in a before-after retrospective study . Ventilation induce Hemodynamic compromise leads to ARDS: Definition: Decrease in mean arterial pressure of 60 mm Hg or an absolute decrease to a systolic blood pressure < 80 mm Hg in the first 2 hours after intubation, required treatment for LTH with vasopressors. primary factor influencing mortality in acute respiratory distress syndrome (ARDS) Incidence: 28.6% of patients intubated in the emergency department developed post-intubation hypotension, tatistically significant association between LTH and hyper carbic (PCO2 > 50 mm) chronic obstructive pulmonary disease


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50
Est. completion date June 30, 2023
Est. primary completion date April 30, 2023
Accepts healthy volunteers
Gender All
Age group 1 Month to 16 Years
Eligibility Inclusion Criteria: - children aged one month to up to 16 years Intubated and connected to MV for at least 48hrs. Exclusion Criteria: - Neonates and cases connected to M.V less than 48 hours.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Mechanical ventilation
type of therapy that helps you breathe or breathes for you when you can't breathe on your own

Locations

Country Name City State
Egypt PICU Assiut Assuit

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (2)

Schouten LR, Veltkamp F, Bos AP, van Woensel JB, Serpa Neto A, Schultz MJ, Wosten-van Asperen RM. Incidence and Mortality of Acute Respiratory Distress Syndrome in Children: A Systematic Review and Meta-Analysis. Crit Care Med. 2016 Apr;44(4):819-29. doi: 10.1097/CCM.0000000000001388. — View Citation

Sud S, Sud M, Friedrich JO, Wunsch H, Meade MO, Ferguson ND, Adhikari NK. High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD004085. doi: 10.1002/14651858.CD004085.pub3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary assess right sided heart failure post ventilator acquired pneumonia use modified ross score for evaluation of heart failure post mechanical ventilation one year from april 2022 to april 2023
Secondary Asess the risk factors associated with barotrauma on mechanical ventilation previous chronic lung disease .previous NICU or PICU admission one year from april 2022 to april 2023
See also
  Status Clinical Trial Phase
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03032380 - Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens Phase 3
Completed NCT01782755 - Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial Phase 2
Completed NCT02440828 - Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia Phase 4
Terminated NCT02652247 - Serial, Non-invasive Analysis of Exhaled Breath Condensate in Ventilated Trauma Patients N/A